1. Malvezzi M, Arfe A, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2012. Ann Oncol. 2012;23(4):1044-52, [
DOI:10.1093/annonc/mds024] [
PMID]
2. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50(3):125-8
3. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL, ISUP grading committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29(9):1228-42. [
DOI:10.1097/01.pas.0000173646.99337.b1] [
PMID]
4. Montie JE. Current prognostic factors for prostate carcinoma. Cancer.1996;78(2):341-4.
https://doi.org/10.1002/(SICI)1097-0142(19960715)78:2<341::AID-CNCR24>3.0.CO;2-V [
DOI:10.1002/(SICI)1097-0142(19960715)78:23.0.CO;2-V]
5. Epstein JI, Pizov G, Walsh PC, Giovannucci E, Mucci LA. Correlation pathological findings with progression after radical retropubic prostatectomy. Cancer. 1993;71(11):3582-93.
https://doi.org/10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y [
DOI:10.1002/1097-0142(19930601)71:113.0.CO;2-Y]
6. Humphrey PA, Frazier HA, Vollmer RT, Paulson DF. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate specific antigen levels. Cancer. 1993;7:1821-7.
https://doi.org/10.1002/1097-0142(19930301)71:5<1821::AID-CNCR2820710517>3.0.CO;2-O [
DOI:10.1002/1097-0142(19930301)71:53.0.CO;2-O]
7. Cecchi M, Minervini R, Sepich CA, Ippolito C, Pagni GL, Summonti D, et al. Correlation between Gleason score of needle biopsy and radical prostatectomy tissue. Int Urol Nephrol. 1998;30(5):575-80. [
DOI:10.1007/BF02550548] [
PMID]
8. Carlson GD, Calvanese CB, Kahane H, Epstein JI. Accuracy of biopsy Gleason scores from a large uropathology laboratory: Use of a diagnostic protocol to minimize observer variability. Urol. 1998;51(4):525-9. [
DOI:10.1016/S0090-4295(98)00002-8]
9. Cookson MS, Fleshner NE, Soloway SM, Fair WR. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: Accuracy and clinical implications. J Urol. 1997;157(2):559-62. [
DOI:10.1016/S0022-5347(01)65201-7]
10. Kojima M, Troncoso P, Babaian RJ. Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error. Urology 1995-45(5):807-12, [
DOI:10.1016/S0090-4295(99)80088-0]
11. Fernandes ET, Sundaram CP, Long R, Soltani M, Ercole CJ. Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol. 1997;79(4):615-7. [
DOI:10.1046/j.1464-410X.1997.00126.x] [
PMID]
12. Epstein JI. The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens. Cancer. 1996;78(2):350-6.
https://doi.org/10.1002/(SICI)1097-0142(19960715)78:2<350::AID-CNCR26>3.0.CO;2-U [
DOI:10.1002/(SICI)1097-0142(19960715)78:23.0.CO;2-U]